Related Experiment Videos

[Atherosclerosis in familial hypercholesteremia possibly induced by defective HDL]

Schweizerische Medizinische Wochenschrift
|March 3, 1984
PubMed

Insights

Familial hypercholesterolemia (FH) is linked to altered lipoprotein composition, specifically lower protein in LDL and increased apo-A II and apo-D in HDL2. These changes in high-density lipoproteins (HDL) may impact their protective role against atherosclerosis.

Area of Science:

  • Lipid metabolism
  • Cardiovascular disease research
  • Biochemistry

Context:

  • Familial hypercholesterolemia (FH) is characterized by elevated, atherogenic low-density lipoproteins (LDL) due to LDL-receptor defects.
  • High-density lipoproteins (HDL) are generally protective against atherosclerosis but are understudied in FH.
  • HDL2's role in cholesterol removal requires further investigation in the context of FH.

Purpose:

  • To compare lipoprotein composition and apolipoprotein profiles in patients with familial hypercholesterolemia (FH) and healthy controls.
  • To investigate potential alterations in HDL2 and HDL3 in FH patients.
  • To explore the relationship between FH, LDL, and HDL subspecies.

Summary:

  • Patients with FH exhibited significantly lower protein content in LDL compared to controls (p < 0.01).
  • HDL2 from FH patients showed significantly higher percentages of apolipoprotein A-II (apo-A II) and apolipoprotein D (apo-D) (p < 0.01).
  • HDL3 from FH patients contained significantly less apolipoprotein E (apo-E) (p < 0.02).

Impact:

  • Findings suggest altered apolipoprotein composition in HDL subspecies in FH, potentially affecting their atheroprotective functions.
  • This study provides new insights into the complex lipid abnormalities in FH beyond LDL elevation.
  • Further research is warranted to elucidate the functional consequences of these compositional changes on atherosclerosis development.

Related Concept Videos